USA - NASDAQ:BRKR - US1167941087 - Common Stock
Taking everything into account, BRKR scores 4 out of 10 in our fundamental rating. BRKR was compared to 57 industry peers in the Life Sciences Tools & Services industry. BRKR has a medium profitability rating, but doesn't score so well on its financial health evaluation. BRKR is not valued too expensively and it also shows a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.26% | ||
| ROE | 4.41% | ||
| ROIC | 4.48% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.69% | ||
| PM (TTM) | 2.31% | ||
| GM | 48.54% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.32 | ||
| Debt/FCF | 49.4 | ||
| Altman-Z | 2.19 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 0.68 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.47 | ||
| Fwd PE | 16.68 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 122.21 | ||
| EV/EBITDA | 15.17 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.52% |
39.71
+0.76 (+1.95%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.52% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.47 | ||
| Fwd PE | 16.68 | ||
| P/S | 1.75 | ||
| P/FCF | 122.21 | ||
| P/OCF | 36.32 | ||
| P/B | 3.34 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.17 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.26% | ||
| ROE | 4.41% | ||
| ROCE | 6.68% | ||
| ROIC | 4.48% | ||
| ROICexc | 4.57% | ||
| ROICexgc | 9.81% | ||
| OM | 9.69% | ||
| PM (TTM) | 2.31% | ||
| GM | 48.54% | ||
| FCFM | 1.43% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.32 | ||
| Debt/FCF | 49.4 | ||
| Debt/EBITDA | 4.37 | ||
| Cap/Depr | 55.42% | ||
| Cap/Sales | 3.39% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.5% | ||
| Profit Quality | 61.93% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 0.68 | ||
| Altman-Z | 2.19 |